Health

New Drug Treats Congenital Blindness

New treatment improves vision in those with an inherited eye disease.

By Connor WaltersJan 22, 2015 4:59 PM
DSC-CR0315_09.jpg
Robert Koenekoop tests a child’s eyesight at the McGill University Health Center in Montreal. | Daniel Héon/McGill University Health Center

Newsletter

Sign up for our email newsletter for the latest science news
 

A new oral drug can improve vision in people with a specific form of blindness, researchers announced in July.

A team led by pediatric ophthalmologist Robert Koenekoop at McGill University gave the medication to 14 patients with Leber congenital amaurosis, an inherited disease that causes retinal degeneration leading to blindness. Ten of the patients, both children and adults, saw their visual field expand, and six experienced improved visual acuity, according to the team’s study, published in The Lancet.

“This is very exciting; we could possibly provide treatment for these disorders that until very recently were considered untreatable,” says Janine Mendola, a McGill neuroscientist involved in the study.

[This article originally appeared in print as "Sight, Seen."]

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 70% off the cover price when you subscribe to Discover magazine.

Copyright © 2021 Kalmbach Media Co.